C Chabannon Selected Research

C Chabannon Research Topics

Disease

8	Neoplasms (Cancer) 11/2019 - 01/2002
8	Breast Neoplasms (Breast Cancer) 01/2017 - 05/2000
4	Lymphoma (Lymphomas) 07/2014 - 04/2001
3	Hodgkin Disease (Hodgkin's Disease) 05/2017 - 12/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2016 - 04/2001
2	Multiple Myeloma 07/2014 - 06/2008
2	Neutropenia 02/2014 - 01/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2009 - 01/2004
1	COVID-19 12/2023
1	Communicable Diseases (Infectious Diseases) 12/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 11/2019
1	Respiratory Insufficiency (Respiratory Failure) 04/2018
1	Bacteremia 04/2018
1	Hemorrhagic Cystitis 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2016
1	Infections 02/2014
1	Mycoses (Diseases, Fungus) 02/2014
1	Invasive Fungal Infections 11/2013
1	Hematologic Diseases (Blood Diseases) 11/2013
1	Aspergillosis 11/2013
1	Hepatitis B 11/2010
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2006
1	Residual Neoplasm 01/2005
1	Ovarian Neoplasms (Ovarian Cancer) 12/2002
1	Carcinoma (Carcinomatosis) 12/2002
1	Carcinogenesis 06/2002
1	Cytopenia 01/2002
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2001
1	Circulating Neoplastic Cells 01/2001
1	Bacterial Infections (Bacterial Infection) 08/2000
1	Anemia 01/2000
1	Agranulocytosis (Granulocytopenia) 01/2000
1	Thrombocytopenia (Thrombopenia) 01/2000

Drug/Important Bio-Agent (IBA)

6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2017 - 06/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2001 - 01/2000
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 11/2010
2	Filgrastim (Neupogen)FDA Link 07/2011 - 01/2002
2	Rituximab (Mabthera)FDA Link 11/2010 - 08/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2002 - 06/2002
1	Chimeric Antigen ReceptorsIBA 01/2022
1	AntigensIBA 08/2019
1	von Willebrand FactorIBA 04/2018
1	Calcineurin InhibitorsIBA 01/2017
1	N 30IBA 02/2016
1	Bendamustine Hydrochloride FDA Link 02/2016
1	Ganciclovir (Cytovene)FDA LinkGeneric 02/2014
1	CreatinineIBA 02/2014
1	Antiviral Agents (Antivirals)IBA 02/2014
1	Voriconazole (Vfend)FDA LinkGeneric 11/2013
1	Micafungin (FK463)FDA Link 11/2013
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2012
1	ancestimIBA 07/2011
1	AntibodiesIBA 11/2010
1	Surface Antigens (Surface Antigen)IBA 11/2010
1	Anti-Idiotypic AntibodiesIBA 11/2010
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2010
1	Hormones (Hormone)IBA 12/2003
1	Carboplatin (JM8)FDA LinkGeneric 12/2002
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2002
1	Proteins (Proteins, Gene)FDA Link 06/2002
1	AutoantibodiesIBA 06/2002
1	Ikaros Transcription FactorIBA 06/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2002
1	pegylated granulocyte colony-stimulating factorIBA 01/2002
1	RNA (Ribonucleic Acid)IBA 09/2001

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2017 - 01/2001
7	Stem Cell Transplantation 12/2023 - 09/2001
6	Therapeutics 12/2023 - 04/2001
5	Transplantation 02/2016 - 08/2000
4	Hematopoietic Stem Cell Transplantation 05/2017 - 01/2016
2	Haploidentical Transplantation 05/2017 - 01/2017
2	Homologous Transplantation 02/2016 - 01/2013
2	Adjuvant Chemotherapy 02/2006 - 06/2002
1	Cell Transplantation 12/2023
1	Autologous Transplantation 02/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2014
1	Salvage Therapy 06/2008
1	Blood Component Removal (Apheresis) 12/2003
1	Laparotomy 12/2002
1	Combination Drug Therapy (Combination Chemotherapy) 01/2002